You are here

You are here

Healthcare

Bioiberica is a global Life Science company with more than 45 years of experience in the identification, extraction and development of molecules of high biological and therapeutic value for the pharmaceutical and nutraceutical industries. ​This specialisation positions Bioiberica among the leading Heparin API manufacturers and as a world reference in the research, production and sale of other biologically-derived APIs and ingredients, such as thyroid, chondroitin sulfate, glucosamine, native type II collagen and hyaluronic acid.

Join our Healthcare Director, Jaume Reguant, for a tour of Bioiberica’s state-of-the-art facilities – watch the video below to discover how we manufacture our innovative nutraceutical and pharmaceutical ingredients.

Healthcare in figures

Since 1992

We're endorsed by
+40

Scientific publications that endorse the effectiveness and safety of our products.

We have treated
+20M

Patients with our products.

We work with
200+

Research centres, universities, companies, and healthcare institutions.

Healthcare stories & news

29 May 2022
Healthcare

With World Digestive Health Day around, shortly followed by World Allergy Awareness Week (5-11 June), we’re exploring the increasing relevance of a relatively unknown digestive health disorder – histamine intolerance. Estimated to affect 1-3% of the global population[i], we’re highlighting five key things you need to know about histamine intolerance, including why it’s quickly becoming a new focus for innovation in the digestive health space. Read on to learn more about this common, yet unmet consumer need.

25 May 2022
Healthcare

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

17 Apr 2022
Healthcare

Bioiberica unveils DAOgest and Dermial® for the first time at Vitafoods 2022.